eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - November 2025, Online, from 19 November 2025, 14:00 (CET) to 21 November 2025, 18:30 (CET)

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - October 2025, Online, from 20 October 2025, 09:00 (CEST) to 22 October 2025, 13:30 (CEST)

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - September 2025, Online, from 17 September 2025, 14:00 (CEST) to 19 September 2025, 18:30 (CEST)

EMEA-002875-PIP02-24

Human medicines European public assessment report (EPAR): Neuraceq, florbetaben (18F), Date of authorisation: 20/02/2014, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Grepid, clopidogrel, Date of authorisation: 27/07/2009, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Nustendi, bempedoic acid,ezetimibe, Date of authorisation: 27/03/2020, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Nilemdo, bempedoic acid, Date of authorisation: 01/04/2020, Revision: 9, Status: Authorised

EMA starts review of sodium oxybate in alcohol dependence

Referral: Sodium oxybate-containing syrup and oral solution for alcohol dependence, sodium oxybate Article 31 referrals Procedure started